RxDoctor Payments DataLook up a doctor →

Justin Parschauer, DO

Ophthalmology · Tulsa, OKNPI 1073845921

Payments from drug & device makers

$884,758in general payments, 2019–2025

Across 486 payments — averaging $1820.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$873K
  • Genentech, Inc.$9K
  • Genentech USA, Inc.$479
  • Regeneron Healthcare Solutions, Inc.$416
  • AbbVie$370
  • Apellis Pharmaceuticals, Inc.$265
  • plus $1K from 11 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$884,758 in reported general payments places this provider in the 95th percentile of 183 ophthalmology providers in Oklahoma.

See all ophthalmology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$4,622,794
Medicare patients
1,056
Services billed
110,903

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →